Hereditary Angioedema Therapeutics Market
Hereditary Angioedema Therapeutics Market Research Report Information by Type (Type I, Type II), By Drug Class (C1 Esterase Inhibitor, Selective Bradykinin B2 Receptor Antagonist, Kallikrein Inhibitor, Others), By Treatment (Prophylaxis - Long-term Prophylaxis, Short-term Prophylaxis, On-demand), By Route of Administration (Intravenous, Subcutaneous, Oral), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and By Region (North America, Europe, Asia Pacific, Rest of the World) - Market Forecast Till 2032
Global Hereditary Angioedema Therapeutics Market Overview
The Hereditary Angioedema Therapeutics Market Size was valued at USD 4.8 billion in 2022 and is projected to grow from USD 5.7 billion in 2023 to USD 12.4 billion by 2032, exhibiting a comp..